Page 10 - Vol.39-No.8 issue

POULTRY

EVONIK AND SHANDONG VLAND BIOTECH

FORM JV IN CHINA WITH FOCUS ON GUT

HEALTH PRODUCTS FOR ANIMALS

says Arron Chen, Chairman and President
of the Vland Group.
Both partners will bring their gut health
businesses - such as probiotics and for-
mulated products - into the joint venture
to cover the Greater China Region. The
Greater China Region accounts for more
than 20 percent of the global feed addi-
Evonik China Co., Ltd and Shandong is an essential element towards Evonik’s tives market.
Vland Biotech Co., Ltd agreed to build a strategy to offer system solutions for its Evonik Vland Biotech (Shandong) Co.,
joint venture to expand their presence in customers in the animal feed industry. Ltd. will also engage in creating new gut
gut health solutions products for farm an- Customized system solutions consist- health products. As part of the agreement,
imals globally. Evonik will be the majority ing of products, services and knowhow Evonik will distribute the joint venture’s
shareholder in this joint venture with 55 delivering sustainability benefits are part portfolio outside of the Greater China Re-
percent of the shares. The joint venture, of the strategic core of Evonik's life sci- gion. The joint venture allows Evonik to
called Evonik Vland Biotech (Shandong) Co., ence division Nutrition & Care, which in- expand its gut health solutions by adding
Ltd. will have its headquarters in Binzhou, cludes the Animal Nutrition business line. broader formulation elements to its global
China, and is planned to enter the market Biosolutions such as probiotics for animal product portfolio.
in Q1/2024. gut health will strengthen the division’s "The joint venture of Evonik and Vland
The joint venture will combine the spe- biotechnology platform. will enhance our portfolio in Asia Pacific.
cific strengths of both partners, including “This joint venture combines the Both companies will grow faster together
Vland's market access, regulatory capabil- strengths of two successful players in than they would have on their own," says
ities in China as well as its fast innovation the feed additives business and provides Shirley Qi, regional president of SEAANZ
cycles. In addition, the joint venture will a solid platform for future growth,” says and head of Nutrition & Care Asia at Evonik.
benefit from Evonik’s global sales force and Dr. Gaetano Blanda, head of the Animal The aim of Evonik’s gut health solutions
market access, R&D and global regulatory Nutrition business line of Evonik. “Together, is to maintain the productivity of farm an-
capabilities. Sales of the new joint venture both partners gain broader market access imals without using antibiotic growth pro-
are expected to be in the low double-digit for their products and combine their in- moters (AGPs). Today, probiotics such as
million euro range.
novative strength.” Ecobiol®, Fecinor®, GutPlus® and GutCare®
Evonik announced earlier this year that it "I am happy to join forces with Evonik. are the basis of this portfolio. They consist
is developing its specialty nutrition business The joint venture builds on the successful of living microorganisms added to animal
with system solutions and specialties for cooperation between our two companies, feed to maintain or restore the microbial
poultry, swine and ruminants. The part- which we are now taking to a new level," balance in the animal’s gut, helping to make
nership with Vland on gut health solutions animals more resilient.

8 Vol. 39 No. 8
Circle 9 on enquiry card